(Total Views: 86)
Posted On: 09/23/2022 1:20:50 PM
Post# of 40431
$MYNZ announced in late June that the company had enrolled the first patient in ColoFuture, an international clinical study assessing the potential to integrate a portfolio of novel gene expression (mRNA) biomarkers into ColoAlert.
(0)
(0)
